Bolt Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Bolt Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Bolt Biotherapeutics Inc
Rating: 1.76308325
Author: Trendlyne DVM scores

about

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

5.09 0.18 (3.67%)

New 52W Low in past week

12,492

XNAS Volume

XNAS 24 Feb, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

29.3 / 100

Technically Neutral

41.2 / 100

1Yr Price target upside is 332%

4 analysts

Bolt Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bolt Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloi...

New 52W Low in past week

SWOT Analysis

Bolt Biotherapeutics Inc Live Price Chart